Year |
Citation |
Score |
2009 |
Burton NC, Schneider JS, Syversen T, Guilarte TR. Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain. Toxicological Sciences : An Official Journal of the Society of Toxicology. 111: 131-9. PMID 19520674 DOI: 10.1093/Toxsci/Kfp124 |
0.556 |
|
2009 |
Burton NC, Guilarte TR. Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environmental Health Perspectives. 117: 325-32. PMID 19337503 DOI: 10.1289/Ehp.0800035 |
0.536 |
|
2008 |
Guilarte TR, Burton NC, McGlothan JL, Verina T, Zhou Y, Alexander M, Pham L, Griswold M, Wong DF, Syversen T, Schneider JS. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. Journal of Neurochemistry. 107: 1236-47. PMID 18808452 DOI: 10.1111/J.1471-4159.2008.05695.X |
0.592 |
|
2008 |
Guilarte TR, Burton NC, Verina T, Prabhu VV, Becker KG, Syversen T, Schneider JS. Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. Journal of Neurochemistry. 105: 1948-59. PMID 18284614 DOI: 10.1111/J.1471-4159.2008.05295.X |
0.538 |
|
2008 |
Chen MK, Kuwabara H, Zhou Y, Adams RJ, Brasić JR, McGlothan JL, Verina T, Burton NC, Alexander M, Kumar A, Wong DF, Guilarte TR. VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease. Journal of Neurochemistry. 105: 78-90. PMID 17988241 DOI: 10.1111/J.1471-4159.2007.05108.X |
0.57 |
|
2007 |
Yates MS, Tauchi M, Katsuoka F, Flanders KC, Liby KT, Honda T, Gribble GW, Johnson DA, Johnson JA, Burton NC, Guilarte TR, Yamamoto M, Sporn MB, Kensler TW. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Molecular Cancer Therapeutics. 6: 154-62. PMID 17237276 DOI: 10.1158/1535-7163.Mct-06-0516 |
0.499 |
|
2006 |
Burton NC, Kensler TW, Guilarte TR. In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology. 27: 1094-100. PMID 16959318 DOI: 10.1016/J.Neuro.2006.07.019 |
0.572 |
|
Show low-probability matches. |